BIASIOLO, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.526
AS - Asia 3.581
EU - Europa 2.304
AF - Africa 917
SA - Sud America 835
OC - Oceania 86
Continente sconosciuto - Info sul continente non disponibili 34
Totale 15.283
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.067
SG - Singapore 1.307
CN - Cina 780
BR - Brasile 498
HK - Hong Kong 369
IT - Italia 326
DE - Germania 298
VN - Vietnam 242
FI - Finlandia 234
SE - Svezia 169
PL - Polonia 145
GB - Regno Unito 116
UA - Ucraina 113
IN - India 89
RU - Federazione Russa 89
FR - Francia 83
NL - Olanda 69
AR - Argentina 54
AT - Austria 53
EC - Ecuador 48
MX - Messico 45
JP - Giappone 44
ES - Italia 42
VE - Venezuela 42
LC - Santa Lucia 40
ZA - Sudafrica 40
MA - Marocco 39
CA - Canada 37
CZ - Repubblica Ceca 37
TR - Turchia 36
CO - Colombia 35
KR - Corea 35
PY - Paraguay 35
AL - Albania 34
IE - Irlanda 33
YT - Mayotte 33
PE - Perù 32
JM - Giamaica 31
AO - Angola 30
EG - Egitto 30
JO - Giordania 30
AZ - Azerbaigian 29
CI - Costa d'Avorio 29
CY - Cipro 29
ET - Etiopia 29
ID - Indonesia 29
AE - Emirati Arabi Uniti 28
IQ - Iraq 28
LY - Libia 28
SA - Arabia Saudita 28
TN - Tunisia 28
UY - Uruguay 28
BE - Belgio 27
IR - Iran 27
MN - Mongolia 27
MR - Mauritania 27
MW - Malawi 27
PH - Filippine 27
UZ - Uzbekistan 27
DZ - Algeria 26
KG - Kirghizistan 26
ME - Montenegro 26
MY - Malesia 26
SD - Sudan 26
SK - Slovacchia (Repubblica Slovacca) 26
BF - Burkina Faso 25
BZ - Belize 25
LA - Repubblica Popolare Democratica del Laos 25
MK - Macedonia 25
ML - Mali 25
PK - Pakistan 25
HR - Croazia 24
IS - Islanda 24
NP - Nepal 24
CR - Costa Rica 23
CU - Cuba 23
CV - Capo Verde 23
TT - Trinidad e Tobago 23
BD - Bangladesh 22
CG - Congo 22
CL - Cile 22
GA - Gabon 22
GF - Guiana Francese 22
GT - Guatemala 22
IL - Israele 22
LB - Libano 22
PA - Panama 22
PT - Portogallo 22
RO - Romania 22
TW - Taiwan 22
GH - Ghana 21
HN - Honduras 21
MG - Madagascar 21
MU - Mauritius 21
NO - Norvegia 21
SN - Senegal 21
UG - Uganda 21
BB - Barbados 20
BJ - Benin 20
CM - Camerun 20
Totale 14.352
Salva come PNG Salva come JPEG
Città #
Fairfield 816
Singapore 736
Ashburn 723
Chandler 579
Jacksonville 509
Woodbridge 485
Houston 430
Hong Kong 348
Wilmington 347
Cambridge 330
Ann Arbor 310
Seattle 291
Beijing 180
Boardman 177
Princeton 169
Santa Clara 160
Bytom 112
Helsinki 101
Padova 96
San Diego 94
Los Angeles 86
Nanjing 86
Des Moines 75
Medford 73
Munich 71
Ho Chi Minh City 69
Roxbury 63
Dong Ket 54
Dearborn 45
São Paulo 43
Guangzhou 42
Hanoi 42
New York 39
Castries 37
Pune 36
Shenyang 35
Hefei 34
Chicago 32
Amman 30
Milan 30
Tokyo 30
Abidjan 29
Nuremberg 29
Turku 28
Vienna 27
Baku 26
Bishkek 26
Jinan 26
Nouakchott 26
Ulan Bator 26
Changsha 25
London 25
Bamako 24
Hebei 24
Luanda 24
Nanchang 24
Dublin 23
Montevideo 23
Podgorica 23
Tashkent 23
Addis Ababa 22
Havana 22
Libreville 22
Buffalo 21
Panama City 21
Brooklyn 20
Falls Church 20
Johannesburg 20
Kampala 20
Kingston 20
Vientiane 20
Accra 19
Andorra la Vella 19
Antananarivo 19
Cotonou 19
Dakar 19
Lilongwe 19
Lima 19
Mamoudzou 19
Montreal 19
Tirana 19
Conakry 18
Guayaquil 18
Kigali 18
Lusaka 18
Ouagadougou 18
Tripoli 18
Dushanbe 17
Frankfurt am Main 17
Maputo 17
Praia 17
Quito 17
Warsaw 17
Niamey 16
Norwalk 16
Noumea 16
Rome 16
San José 16
Willemstad 16
Yerevan 16
Totale 9.266
Salva come PNG Salva come JPEG
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 279
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 248
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 246
APC I1307K mutations and forkhead box gene (FOXO1A): another piece of an interesting correlation. 215
Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma 201
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 196
SERPINB3 delays glomerulonephritis and attenuates the lupus-like disease in lupus murine models by inducing a more tolerogenic immune phenotype 193
Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular carcinoma 190
A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses 188
1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition 186
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. 177
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. 176
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis 172
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 171
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 170
Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer: A Phase III Study 167
ANTIPHOSPHOLIPID ANTIBODIES ARE NOT PRESENT IN THE MEMBRANE OF GEL-FILTERED PLATELETS OF PATIENTS WITH IGG ANTICARDIOLIPIN ANTIBODIES, LUPUS ANTICOAGULANT AND THROMBOSIS 166
A comparison between six- and four-week intervals in surveillance of oral anticoagulant treatment 166
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 166
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 165
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 161
Use of a new silica clotting time for diagnosing lupus anticoagulant in patients who meet the clinical criteria for antiphospholipid syndrome 159
SQUAMOUS CELL CARCINOMA ANTIGEN- IMMUNOGLOBULIN M (SCCA-IGM) AS BIOMARKER IN LIVER DISEASE: BIOLOGICAL ASPECTS AND CLINICAL APPLICATIONS 157
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 156
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study 155
Serpinb3 is overexpressed in the liver in presence of iron overload 155
A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants 149
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients 149
A comparison of lupus anticoagulant-positive patients with clinical picture of Antiphospholipid syndrome and those without 144
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis. 144
Immunosuppressive treatment in a heart transplantation candidate with antiphospholipid syndrome 143
Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis 143
A simple scheme to initiate oral anticoagulant treatment in outpatients with nonrheumatic atrial fibrillation 143
BINDING OF AUTOIMMUNE CARDIOLIPIN-REACTIVE ANTIBODIES TO HEPARIN - A MECHANISM OF THROMBOSIS 141
[Anti-beta(2) glycoprotein I beta(2) glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases 140
Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma 140
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 140
Engineered EVs for oxidative stress protection 139
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma 139
Purification of anticardiolipin and lupus anticoagulant activities by using cardiolipin immobilized on agarose beads. 138
Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when β2-glycoprotein I is bound to a suitable surface 134
The Protease Activated Receptor 2 - CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of Non-Alcoholic Steatohepatitis 133
Immunosuppressive treatment in a heart transplantation candidate with antiphospholipid syndrome. 132
Relapse after direct-acting antivirals (DAAs) in cirrhotic patients with hepatitis C is highly related to development of liver cancer 132
1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2 131
Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins 131
Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma 131
Accuracy of a portable prothrombin time monitor (Coagucheck) in patients on chronic anticoagulant therapy: a prospective multicenter study 130
SERPINB3 is associated with longer survival in transgenic mice. 130
SERPINB3 AS A PRO-INFLAMMATORY MEDIATOR IN THE PROGRESSION OF EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE. 129
[IgG anti-beta 2-glycoprotein I beta 2-glycoprotein I] immune complexes in patients with antiphospholipid (aPL) syndrome 128
Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis 128
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 127
PURIFICATION OF ANTICARDIOLIPIN AND LUPUS ANTICOAGULANT ACTIVITIES BY USING CARDIOLIPIN IMMOBILIZED ON AGAROSE BEADS 127
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 127
Monitoring SCCA-IgM complex predicts liver disease progression in patients with chronic hepatitis and cirrhosis 125
Hepatic progenitor cells overexpress SERPINB3 in a mouse model of fulminant hepatitis 123
RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA 123
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition 122
Low intensity warfarin therapy. 120
Serum and bile squamous cell carcinoma antigen 1 (SCCA1) detection: a new diagnostic approach in patients with perihilar cholangiocarcinoma (pCCA) 120
Increased antiprotease activity of the SerpinB3 polymorphic variant SCCA-PD 119
COMBINING SCCA-IGM AND AFP-IGM LEVELS INCREASES ACCURACY OF HEPATOCELLULAR CARCINOMA DETECTION 119
Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients 117
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 117
SCCA-IGM USEFULNESS TO MONITOR PATIENTS WITH CIRRHOSIS IS NOT AFFECTED BY INTERFERING IGM'S 115
Cellule progenitrici epatiche esprimono SERPINB3b in un modello murino di epatite fulminante 114
SerpinB3/Protease Activated Receptor-2 Axis Is Essential for SARS CoV-2 Infection 113
Anti phospholipid antibody ELISAs: Survey on the performance of clinical laboratories assessed by using lyophilized affinity-purifled IgG with anticardiolipin and anti-beta 2-glycoprotein I activity 113
POLIMORFISMO DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E PROGRESSIONE DELLA MALATTIA EPATICA NELL’INFEZIOE HCV 113
REVERSAL OF EXCESSIVE EFFECT OF REGULAR ANTICOAGULATION - LOW ORAL DOSE OF PHYTONADIONE (VITAMIN-K1) COMPARED WITH WARFARIN DISCONTINUATION 112
Modulazione dei livelli di IL-6 nella rigenerazione epatica da parte di SERPINB3 ed estrogeni. Analisi in un modello di topo transgenico 112
Bile detection of squamous cell carcinoma antigen (SCCA) in extrahepatic cholangiocarcinoma 111
HPYPOXYA UP-REGULATES SERPINB3 IN HEPATIC CANCER CELLS: A HIF-2a ASSOCIATED EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 111
SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA) ENHANCES LIVER REGENERATION AFTER PARTIAL HEPATECTOMY 111
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo 110
SERPINB3 modulates TGF-beta expression in chronic liver disease. 110
HYPOXIA UP-REGULATES SERPINB3 IN HEPG2 CELLS: A REDOX SENSITIVE EVENT RELATED TOEPITHELIAL TO MESENCHYMAL TRANSITIONAND INVASIVENESS 108
COMPORTAMENTO DI SCCA-IgM NEL SIERO DI BAMBINI HBeAg POSITIVI SEGUITI NEL TEMPO 108
OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY 106
CHARACTERIZATION OF SCCA-1(SERPINB3) ISOFORMS IN HEPATOCELLULAR CARCINOMA 106
SerpinB3 administration protects liver against ischemia-reperfusion injury 105
Sex dependent IL-6 deregulation by SERPINB3 in a transgenic mouse model 105
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 103
Lupus anticoagulant (LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity 103
Effect of anti-beta-2-glycoprotein I Lupus Anticoagulants on fibrin polymerization and fibrinolysis 102
Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers 101
Autoimmune antiphospholipid antibodies: What is their true target? 100
Mechanical prosthetic heart valve thrombosis despite optimal anticoagulation in a patient with congenital thrombophilia (factor V Leiden) 98
MATRIX METALLOPROTEINASE 9 (MMP9)-IgM COMPLEX: AN EMERGING NOVEL BIOMARKER IN COLORECTAL CANCER 97
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis 97
Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids. 96
LRP-1 BINDS SERPINB3 AND MEDIATES ITS MIGRATORY ACTIVITY 96
SCCA1-IGM AND SCCA2-IGM COMPARED WITH TOTAL SCCA-IGM FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA 95
Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of a portable prothombin time monitor (Coagucheck) 95
SEX DEPENDENT IL-6 DEREGULATION BY SERPINB3 IN A TRANSGENIC MOUSE MODEL 91
CIRCULATING SURVIVIN-IGM IS A NOVEL CANDIDATE BIOMARKER OF CIRRHOSIS AND INCREASES WITH CHILD SCORE IN PATIENTS AFFECTED BY LIVER DISEASES 90
The risk of overdiagnosis of antiphospholipid syndrome 88
Overexpression of SERPINB3 in hepatic progenitor cells in a mouse model of acute liver injury 88
EVALUATION OF THE ANALYTICAL SPECIFICITY OF SCCA-IGM ASSAY FOR MONITORING PATIENTS WITH CIRRHOSIS 87
Totale 13.538
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.457
article - articoli 39.433
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 488
Totale 86.378
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021847 0 0 0 0 0 98 25 88 180 180 140 136
2021/20221.185 23 155 106 103 58 80 61 106 77 19 129 268
2022/20231.159 245 122 61 115 179 168 6 72 131 11 35 14
2023/2024571 22 99 66 37 44 79 38 27 12 17 58 72
2024/20252.752 18 257 118 107 290 78 142 193 219 115 485 730
2025/20265.356 477 886 1.463 1.429 935 166 0 0 0 0 0 0
Totale 15.343